News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Apricus Biosciences (APRI) Issues Statement Regarding Registration of Shares Related to Finesco/Scomedica and PediatRx Transactions


7/17/2012 12:16:43 PM

SAN DIEGO, July 17, 2012 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio") (Nasdaq:APRI) (www.apricusbio.com) today issued the following statement regarding the registration of 3,706,397 shares of the Company's common stock on U.S. Securities and Exchange Commission resale Form S-3, filed yesterday, July 16, 2012:

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES